Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes

Surgery

Volumn 127, Issue 1, 2000, Pages 40-46

  Komukai, Shintaro ^a   Nishimaki, Tadashi ^a   Watanabe, Hidenobu ^a   Ajioka, Yoichi ^a   Suzuki, Tsutomu ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BODY DISTRIBUTION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0033978016     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.102754     Document Type: Article

References (22)

1. 1. Müeller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-57.
2. 2. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
3. 3. Galea MH, Athanassiou E, Bell J, Robertson JF, Elston CW, Blamey RW, et al. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM5.2 and NCRC-11. J Pathol 1991;165:221-7.
4. 4. Greenson JK, Isenhart CE, Rice R, Mujzisik C, Houchens D, Martin Jr EW. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563-9.
5. 5. Jeffers MD, O'Dowd CM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1094;172:183-7.
6. 6. Cutait R, Alves VAF, Lopes LC, Cutait DE, Borges JLA, Singer J, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917-20.
7. 7. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069-76.
8. 8. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastases in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
9. 9. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347:649-53.
10. 10. Nishimaki T, Suzuki T, Kanda T, Obinata I, Komukai S, Hatakeyama K. Extended radical esophagectomy for superficially invasive carcinoma of the esophagus. Surgery 1999;125:142-7.
11. 11. Sohin LH, Wittekind C. TNM classification of malignant tumors. 5th ed. Berlin: Springer, Union Internationale Contre le Cancer (UICC); 1997.
12. 12. Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998;186:306-12.
13. 13. Japanese Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg 1976;6:69-78.
14. 14. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Hatakeyama K. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras. Histopathology 1998;32:199-208.
15. 15. Woodcock MJ, Eichner R, Nelson WG. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982;95:580-8.
16. 16. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-94.
17. 17. Natsugoe S, Mueller J, Stein HJ, Feith M, Höfler H, Siewert JR. Micrometastases and tumor cell microinvolvemenl of lymph nodes from esophageal squamous cell carcinoma. Cancer 1998;83:858-66.
18. 18. Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K, Muto T. Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 1994;74:4-11.
19. 19. Akiyama H, Turumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-73.
20. 20. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, et al. The prognostic significance of lymph node micrometastases in patients with esophageal carcinoma. Cancer 1999;85:769-78.
21. 21. Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995;345:1257-9.
22. 22. Luketich JD, Kassis ES, Shriver SP, Nguyen NT, Schauer PR, Weigel TL, et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 1998;66:1715-8.